A citation-based method for searching scientific literature

Katelin M Allan, Nigel Farrow, Martin Donnelley, Adam Jaffe, Shafagh A Waters. Front Pharmacol 2021
Times Cited: 4







List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
Eric W F W Alton, Jeffery M Beekman, A Christopher Boyd, June Brand, Marianne S Carlon, Mary M Connolly, Mario Chan, Sinead Conlon, Heather E Davidson, Jane C Davies,[...]. Thorax 2017
77
75

Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward.
Ashley L Cooney, Paul B McCray, Patrick L Sinn. Genes (Basel) 2018
47
75

Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma.
Virginie Rollet-Cohen, Matthieu Bourderioux, Joanna Lipecka, Cerina Chhuon, Vincent A Jung, Myriam Mesbahi, Thao Nguyen-Khoa, Sophie Guérin-Pfyffer, Alain Schmitt, Aleksander Edelman,[...]. J Proteomics 2018
23
50

Engineered transfer RNAs for suppression of premature termination codons.
John D Lueck, Jae Seok Yoon, Alfredo Perales-Puchalt, Adam L Mackey, Daniel T Infield, Mark A Behlke, Marshall R Pope, David B Weiner, William R Skach, Paul B McCray,[...]. Nat Commun 2019
33
50

Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.
Allison F McCague, Karen S Raraigh, Matthew J Pellicore, Emily F Davis-Marcisak, Taylor A Evans, Sangwoo T Han, Zhongzhou Lu, Anya T Joynt, Neeraj Sharma, Carlo Castellani,[...]. Am J Respir Crit Care Med 2019
40
50

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.
Eitan Kerem, Michael W Konstan, Kris De Boeck, Frank J Accurso, Isabelle Sermet-Gaudelus, Michael Wilschanski, J Stuart Elborn, Paola Melotti, Inez Bronsveld, Isabelle Fajac,[...]. Lancet Respir Med 2014
224
50

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments.
Hairui Zhang, Jasmim Leal, Melissa R Soto, Hugh D C Smyth, Debadyuti Ghosh. Pharmaceutics 2020
16
50

Modulators of CFTR. Updates on clinical development and future directions.
Emmanuelle Bardin, Alexandra Pastor, Michaela Semeraro, Anita Golec, Kate Hayes, Benoit Chevalier, Farouk Berhal, Guillaume Prestat, Alexandre Hinzpeter, Christine Gravier-Pelletier,[...]. Eur J Med Chem 2021
20
50

Nonsense-mediated mRNA decay in health and disease.
P A Frischmeyer, H C Dietz. Hum Mol Genet 1999
811
50


Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
I Sermet-Gaudelus, M Renouil, A Fajac, L Bidou, B Parbaille, S Pierrot, N Davy, E Bismuth, P Reinert, G Lenoir,[...]. BMC Med 2018
4
50

Cell Therapy for Cystic Fibrosis Lung Disease: Regenerative Basal Cell Amplification.
Don Hayes, Benjamin T Kopp, Cynthia L Hill, Scott W Lallier, Cynthia M Schwartz, Mahelet Tadesse, Alfahdah Alsudayri, Susan D Reynolds. Stem Cells Transl Med 2019
20
50

Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Susana Igreja, Luka A Clarke, Hugo M Botelho, Luís Marques, Margarida D Amaral. Hum Mutat 2016
48
50

Therapeutic promise of engineered nonsense suppressor tRNAs.
Joseph J Porter, Christina S Heil, John D Lueck. Wiley Interdiscip Rev RNA 2021
10
50

Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTR.
Melissa M Keenan, Lulu Huang, Nikole J Jordan, Eric Wong, Yi Cheng, Hillary C Valley, Jerome Mahiou, Feng Liang, Hermann Bihler, Martin Mense,[...]. Am J Respir Cell Mol Biol 2019
27
50

New approaches to genetic therapies for cystic fibrosis.
A Christopher Boyd, Shuling Guo, Lulu Huang, Batsheva Kerem, Yifat S Oren, Amy J Walker, Stephen L Hart. J Cyst Fibros 2020
18
50


Delivering on the promise of gene editing for cystic fibrosis.
Craig A Hodges, Ronald A Conlon. Genes Dis 2018
24
50

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease.
Martijn P T Ernst, Mike Broeders, Pablo Herrero-Hernandez, Esmee Oussoren, Ans T van der Ploeg, W W M Pim Pijnappel. Mol Ther Methods Clin Dev 2020
33
50

Mesenchymal Stem Cell exosome delivered Zinc Finger Protein activation of cystic fibrosis transmembrane conductance regulator.
Olga Villamizar, Shafagh A Waters, Tristan Scott, Nicole Grepo, Adam Jaffe, Kevin V Morris. J Extracell Vesicles 2021
11
50

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis.
Andrew Berical, Rhianna E Lee, Scott H Randell, Finn Hawkins. Front Pharmacol 2019
28
50

New Directions in Pulmonary Gene Therapy.
Amber Vu, Paul B McCray. Hum Gene Ther 2020
3
66

Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis.
Isabelle Sermet-Gaudelus, John P Clancy, David P Nichols, Jerry A Nick, Kris De Boeck, George M Solomon, Marcus A Mall, James Bolognese, Florilene Bouisset, Wilhelmina den Hollander,[...]. J Cyst Fibros 2019
24
50

A meta-analysis of nonsense mutations causing human genetic disease.
Matthew Mort, Dobril Ivanov, David N Cooper, Nadia A Chuzhanova. Hum Mutat 2008
216
50

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.
Gerald Schwank, Bon-Kyoung Koo, Valentina Sasselli, Johanna F Dekkers, Inha Heo, Turan Demircan, Nobuo Sasaki, Sander Boymans, Edwin Cuppen, Cornelis K van der Ent,[...]. Cell Stem Cell 2013
793
50

mRNA as a versatile tool for exogenous protein expression.
Andreas N Kuhn, Tim Beiβert, Petra Simon, Britta Vallazza, Janina Buck, Brian P Davies, Ozlem Tureci, Ugur Sahin. Curr Gene Ther 2012
38
50



Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.
Malena Cohen-Cymberknoh, David Shoseyov, Eitan Kerem. Am J Respir Crit Care Med 2011
188
50

Splicing regulation as a potential genetic modifier.
Malka Nissim-Rafinia, Batsheva Kerem. Trends Genet 2002
164
50

Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis.
Ema Robinson, Kelvin D MacDonald, Kai Slaughter, Madison McKinney, Siddharth Patel, Conroy Sun, Gaurav Sahay. Mol Ther 2018
82
50

Efficient Gene Editing at Major CFTR Mutation Loci.
Jinxue Ruan, Hiroyuki Hirai, Dongshan Yang, Linyuan Ma, Xia Hou, Hong Jiang, Hongguang Wei, Carthic Rajagopalan, Hongmei Mou, Guoshun Wang,[...]. Mol Ther Nucleic Acids 2019
38
50

Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis.
Wouter Beumer, Jim Swildens, Teresinha Leal, Sabrina Noel, Herma Anthonijsz, Geert van der Horst, Hester Kuiperij-Boersma, Marko Potman, Charlotte van Putten, Patricia Biasutto,[...]. PLoS One 2019
11
50

Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
Michael Wilschanski, Yaacov Yahav, Yasmin Yaacov, Hannah Blau, Lea Bentur, Joseph Rivlin, Micha Aviram, Tali Bdolah-Abram, Zsuzsa Bebok, Liat Shushi,[...]. N Engl J Med 2003
371
50

Pre-mRNA splicing and human disease.
Nuno André Faustino, Thomas A Cooper. Genes Dev 2003
913
50

The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells.
Sarah X L Huang, Michael D Green, Ana Toste de Carvalho, Melanie Mumau, Ya-Wen Chen, Sunita L D'Souza, Hans-Willem Snoeck. Nat Protoc 2015
110
50

Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
Ana M Crane, Philipp Kramer, Jacquelin H Bui, Wook Joon Chung, Xuan Shirley Li, Manuel L Gonzalez-Garay, Finn Hawkins, Wei Liao, Daniela Mora, Sangbum Choi,[...]. Stem Cell Reports 2015
116
50

Derivation of Airway Basal Stem Cells from Human Pluripotent Stem Cells.
Finn J Hawkins, Shingo Suzuki, Mary Lou Beermann, Cristina Barillà, Ruobing Wang, Carlos Villacorta-Martin, Andrew Berical, J C Jean, Jake Le Suer, Taylor Matte,[...]. Cell Stem Cell 2021
44
50

Treating Cystic Fibrosis with mRNA and CRISPR.
Alejandro Da Silva Sanchez, Kalina Paunovska, Ana Cristian, James E Dahlman. Hum Gene Ther 2020
12
50



Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation.
Andrea Gramegna, Martina Contarini, Francesco Bindo, Stefano Aliberti, Francesco Blasi. Curr Opin Pharmacol 2021
5
50


Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
J R Riordan, J M Rommens, B Kerem, N Alon, R Rozmahel, Z Grzelczak, J Zielenski, S Lok, N Plavsic, J L Chou. Science 1989
50

Pharmacological approaches for targeting cystic fibrosis nonsense mutations.
Jyoti Sharma, Kim M Keeling, Steven M Rowe. Eur J Med Chem 2020
16
50

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons.
Iwona Pranke, Laure Bidou, Natacha Martin, Sandra Blanchet, Aurélie Hatton, Sabrina Karri, David Cornu, Bruno Costes, Benoit Chevalier, Danielle Tondelier,[...]. ERJ Open Res 2018
25
50

A revised airway epithelial hierarchy includes CFTR-expressing ionocytes.
Daniel T Montoro, Adam L Haber, Moshe Biton, Vladimir Vinarsky, Brian Lin, Susan E Birket, Feng Yuan, Sijia Chen, Hui Min Leung, Jorge Villoria,[...]. Nature 2018
453
50

Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis.
Pavel Drevinek, Tacjana Pressler, Marco Cipolli, Kris De Boeck, Carsten Schwarz, Florilene Bouisset, Marie Boff, Noreen Henig, Nicolas Paquette-Lamontagne, Sonya Montgomery,[...]. J Cyst Fibros 2020
24
50

On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis.
Marjolein Ensinck, Angélique Mottais, Claire Detry, Teresinha Leal, Marianne S Carlon. Front Pharmacol 2021
6
50

Muco-Obstructive Lung Diseases.
Richard C Boucher. N Engl J Med 2019
115
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.